- Six world-first vaccines among USask’s VIDO-InterVac contributions to global health
VIDO-InterVac has established itself as a leading global institute in protecting human and animal health since 1975, with six world-firsts among the eight vaccines it has commercialized.
- Volker Gerdts Named as New VIDO-InterVac Director and CEO
Following an international search, Dr. Volker Gerdts has been selected to lead the University of Saskatchewan’s Vaccine and Infectious Disease Organization-International Vaccine Centre.
- Local outbreak of whooping cough has Sask. health officials calling on parents to make sure kids vaccinations are up to date
A cluster of whooping cough cases among children in communities surrounding Saskatoon since October has led provincial health officials to issue warnings.
- How a new vaccine could save cattle herds – and livelihoods
For 10,000 years, the bacterium Mycoplasma mycoides has infected goats, cows and other livestock, annihilating entire herds in days.
- Young Innovators: Innovative research finds influenza detection system in body
University of Saskatchewan researchers have found a unique “sensor” mechanism inside cells that enables the immune system to recognize influenza, a finding that may lead to improved vaccines in the future.
- Young Innovators: U of S research team aims to develop salmonella vaccine
Researchers have been working on a novel salmonella vaccine that holds promise for preventing this food-borne infection. The vaccine, being developed at the university’s VIDO-InterVac, has shown positive preliminary results in animal models.
- Early research promising for new sheep respiratory vaccine
Research into the development of a new vaccine to help fight respiratory problems in lambs is showing encouraging early results.
- Federal investment helps bring vaccine manufacturing facility to Saskatoon
A vaccine manufacturing plant is set to take up residence at the VIDO-InterVac on the U of S campus.
- U of S gets major federal boost for isotope and vaccine production, water research
$3.6M investment towards the establishment of a vaccine manufacturing facility.
- International Partnership Results in New Vaccine for Cattle in Africa
A vaccine against contagious bovine pleuropneumonia has been licensed for commercial production by the Kenya Veterinary Vaccines Production Institute.